Euromedis Groupe Stock Forecast for 2023 - 2025 - 2030

Updated on 05/04/2024

Stock Rating
14
Price Target
4.00€
Consensus
Underperform
Downside
-15.79%
Analysts
1
Stock Rating
14
Downside
-15.79%
Analysts
1
Price Target
4.00€

Euromedis Groupe Stock Forecast and Price Target

Based on the current earnings figures, this year's price targets for Euromedis Groupe were recently set by distinguished experts, with an average mark of 4.00€. If it reached this goal, it would represent a potential downside of approximately -15.79% from the previous closing price in May, 2024. The high end is 4.00€, and the low is 4.00€. Even if you're not interested in ALEMG stock, you may be interested in its competitors.

4.00€

-15.79% Downside

Underperform
Underperform

Euromedis Groupe Fair Value Forecast for 2023 - 2025 - 2030

In the last four years, Euromedis Groupe has seen a decline in its Price, from 3.43€ to 0.00€ – a 100.00% decrease. In the next year, analysts believe that Fair Value will reach 0.22€ – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.

2024 Fair Value Forecast
0.22€
2025 Fair Value Forecast
0.23€
2026 Fair Value Forecast
0.23€
2027 Fair Value Forecast
0.15€
2028 Fair Value Forecast
0.17€
2029 Fair Value Forecast
0.20€
2030 Fair Value Forecast
0.21€

Euromedis Groupe Revenue Forecast for 2023 - 2025 - 2030

In the last two years, Euromedis Groupe has seen a decline in its Revenue, from 193.40€M to 54.18€M – a 71.99% decrease. In the next year, analysts believe that Revenue will reach 62.85€M – an increase of 16.00%. For the next seven years, the forecast is for Revenue to grow by 39.79%.

2024 Rev Forecast
0.06€B
2025 Rev Forecast
0.07€B
2026 Rev Forecast
0.09€B
2027 Rev Forecast
0.07€B
2028 Rev Forecast
0.07€B
2029 Rev Forecast
0.07€B
2030 Rev Forecast
0.08€B

Euromedis Groupe Dividend per Share Forecast for 2023 - 2025 - 2030

2024 DPS Forecast
0.00€

Euromedis Groupe Free Cash Flow Forecast for 2023 - 2025 - 2030

2024 FCF Forecast
0.00€B
2025 FCF Forecast
0.00€B
2026 FCF Forecast
0.00€B
2027 FCF Forecast
0.00€B
2028 FCF Forecast
0.00€B
2029 FCF Forecast
0.00€B
2030 FCF Forecast
0.00€B

Euromedis Groupe EBITDA Forecast for 2023 - 2025 - 2030

Euromedis Groupe's EBITDA has decreased In the last two years, from 32.14€M to -4.01€M – a 112.48% drop. In the following year, 1 experts forecast Euromedis Groupe's EBITDA will decrease by 172.07%, to 2.89€M. In 2030, professionals predict that Euromedis Groupe's EBITDA will decrease by 250.12%, to 6.02€M.

2024 EBITDA Forecast
0.00€B
2025 EBITDA Forecast
0.00€B
2026 EBITDA Forecast
0.00€B
2027 EBITDA Forecast
581.90€k
2028 EBITDA Forecast
0.00€B
2029 EBITDA Forecast
0.00€B
2030 EBITDA Forecast
0.01€B

Euromedis Groupe EBIT Forecast for 2023 - 2025 - 2030

In the last two years, Euromedis Groupe's EBIT has seen a drop from 30.99€M to -5.14€M – a 116.59% decrease. According to 1 major analysts, Euromedis Groupe's EBIT will fall by 136.96% in the next year, reaching 1.90€M. Professionals believe that By 2030, Euromedis Groupe's EBIT will fall to 1.47€M– a 128.52% decrease from its current value.

2024 EBIT Forecast
0.00€B
2025 EBIT Forecast
0.00€B
2026 EBIT Forecast
726.07€k
2027 EBIT Forecast
241.85€k
2028 EBIT Forecast
540.68€k
2029 EBIT Forecast
0.00€B
2030 EBIT Forecast
0.00€B

Euromedis Groupe EPS Price Prediction Forecast for 2023 - 2025 - 2030

In the last four years, Euromedis Groupe has seen a decline in its EPS, from 6.35€ to 0.00€ – a 100.00% decrease. In the next year, analysts believe that EPS will reach 0.40€ – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.

2024 EPS Forecast
0.40€
2025 EPS Forecast
0.43€
2026 EPS Forecast
0.42€
2027 EPS Forecast
0.27€
2028 EPS Forecast
0.32€
2029 EPS Forecast
0.36€
2030 EPS Forecast
0.40€